The Livingston, N.J.-based electronic cigarette maker has tapped Dr. Keith Ablow to conduct an expanded clinical study of Logic e-cigarettes in his psychiatry practice to determine their effects on reducing or eliminating tobacco product usage. Ablow previously reported that three individuals had stopped smoking when given e-cigarettes as part of a smoking cessation regimen.
The 12-week study will monitor and track patients' experiences using electronic cigarettes to determine the products’ effectiveness for transitioning smokers from traditional cigarettes to the tobacco-free, smokeless, battery-operated nicotine delivery devices.
"We are thrilled to work with distinguished psychiatrist Dr. Keith Ablow to conduct this study," said Eli Alelov, CEO of Logic Technology. "Minimal statistical data exists about electronic cigarettes and their effectiveness in supporting a switch from traditional cigarettes, and we think it is imperative to educate the public on the benefits of this product."
The most recent Nielsen Brand Rank Report found that Logic outperformed all e-cigarette brands in the first quarter of 2013 for sales per point of distribution. Based on sales from convenience stores across the United States, the Nielsen Brand Rank Report showed Logic's Black Label was the most preferred in the electronic cigarette category. In addition, Logic's Platinum Label was the second-highest-selling electronic cigarette.
As the study moves forward, Logic will provide updates on the findings:
Source Link:
